Literature DB >> 6224421

Biochemical defect of non-keratan-sulfate-excreting Morquio syndrome.

A Fujimoto, A L Horwitz.   

Abstract

Two children of second-cousin parents were found to have a very mild form of Morquio syndrome. The 14-year-old boy was 147 cm tall and had fine corneal deposits, a broad chest, dislocated hips, and flat feet. His 7-year-old sister had a broad chest but otherwise normal physical development. An abnormal lumbar spine was seen in radiographs of both children. Analysis of the urine from the affected children showed levels of acid mucopolysaccharides (AMPS) up to twice as high as that found in normal urine, but no evidence of keratosulfaturia. Most urinary AMPS was chondroitin-6-sulfate. Multiple assays of N-acetylgalactosamine-6-sulfate (GalNAc-6-SO4) sulfatase in leukocytes and cultured skin fibroblasts showed deficiency of this enzyme in the range found in the classical form of Morquio (Morquio A) syndrome. This report identifies an enzymatic defect in one form of non-keratan-sulfate-excreting Morquio (NKSE Morquio) syndrome and confirms the absence of keratosulfaturia in this mild form of Morquio disease.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6224421     DOI: 10.1002/ajmg.1320150210

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  11 in total

1.  Ocular histopathology and ultrastructure of Morquio syndrome (systemic mucopolysaccharidosis IV A).

Authors:  M Iwamoto; Y Nawa; I H Maumenee; J Young-Ramsaran; R Matalon; W R Green
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1990       Impact factor: 3.117

2.  Mucopolysaccharidosis IVA: a comparative study of polymorphic DNA haplotypes in the Caucasian and Japanese populations.

Authors:  G M Rezvi; S Tomatsu; S Fukuda; A Yamagishi; A Cooper; J E Wraith; H Iwata; Z Kato; N Yamada; K Sukegawa; N Shimozawa; Y Suzuki; N Kondo; T Orii
Journal:  J Inherit Metab Dis       Date:  1996       Impact factor: 4.982

3.  Mucopolysaccharidosis type IVA. N-acetylgalactosamine-6-sulfate sulfatase exonic point mutations in classical Morquio and mild cases.

Authors:  S Fukuda; S Tomatsu; M Masue; K Sukegawa; H Iwata; T Ogawa; Y Nakashima; T Hori; A Yamagishi; Y Hanyu
Journal:  J Clin Invest       Date:  1992-09       Impact factor: 14.808

4.  Mucopolysaccharidosis IVA: polymorphic haplotypes and informative RFLPs in the Japanese population.

Authors:  H Iwata; S Tomatsu; S Fukuda; A Uchiyama; G M Rezvi; T Ogawa; T Hori; Y Nakashima; A Yamagishi; K Sukegawa
Journal:  Hum Genet       Date:  1995-03       Impact factor: 4.132

5.  Diagnosis of classical Morquio's disease: N-acetylgalactosamine 6-sulphate sulphatase activity in cultured fibroblasts, leukocytes, amniotic cells and chorionic villi.

Authors:  M Yuen; A H Fensom
Journal:  J Inherit Metab Dis       Date:  1985       Impact factor: 4.982

6.  Validation of keratan sulfate level in mucopolysaccharidosis type IVA by liquid chromatography-tandem mass spectrometry.

Authors:  Shunji Tomatsu; Adriana M Montaño; Toshihiro Oguma; Vu Chi Dung; Hirotaka Oikawa; Talita Giacomet de Carvalho; María L Gutiérrez; Seiji Yamaguchi; Yasuyuki Suzuki; Masaru Fukushi; Kazuhiro Kida; Mitsuru Kubota; Luis Barrera; Tadao Orii
Journal:  J Inherit Metab Dis       Date:  2010-01-27       Impact factor: 4.982

7.  Elosulfase alfa for mucopolysaccharidosis type IVA: Real-world experience in 7 patients from the Spanish Morquio-A early access program.

Authors:  Guillem Pintos-Morell; Javier Blasco-Alonso; María L Couce; Luís G Gutiérrez-Solana; Encarna Guillén-Navarro; Mar O'Callaghan; Mireia Del Toro
Journal:  Mol Genet Metab Rep       Date:  2018-04-05

8.  Enzyme replacement therapy for treating mucopolysaccharidosis type IVA (Morquio A syndrome): effect and limitations.

Authors:  Shunji Tomatsu; Kazuki Sawamoto; Tsutomu Shimada; Michael B Bober; Francyne Kubaski; Eriko Yasuda; Robert W Mason; Shaukat Khan; Carlos J Alméciga-Díaz; Luis A Barrera; William G Mackenzie; Tadao Orii
Journal:  Expert Opin Orphan Drugs       Date:  2015-10-29       Impact factor: 0.694

9.  Diagnosing mucopolysaccharidosis IVA.

Authors:  Timothy C Wood; Katie Harvey; Michael Beck; Maira Graeff Burin; Yin-Hsiu Chien; Heather J Church; Vânia D'Almeida; Otto P van Diggelen; Michael Fietz; Roberto Giugliani; Paul Harmatz; Sara M Hawley; Wuh-Liang Hwu; David Ketteridge; Zoltan Lukacs; Nicole Miller; Marzia Pasquali; Andrea Schenone; Jerry N Thompson; Karen Tylee; Chunli Yu; Christian J Hendriksz
Journal:  J Inherit Metab Dis       Date:  2013-02-01       Impact factor: 4.982

10.  Bisphosphonate Treatment in a Patient Affected by MPS IVA with Osteoporotic Phenotype.

Authors:  Albina Tummolo; Orazio Gabrielli; Alberto Gaeta; Maristella Masciopinto; Lucia Zampini; Luigi Michele Pavone; Paola Di Natale; Francesco Papadia
Journal:  Case Rep Med       Date:  2013-11-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.